{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:43:18Z","timestamp":1773931398765,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11680-7","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:52:07Z","timestamp":1773917527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanisms of circadian clock-mediated gene regulation and their implications in leukemia"],"prefix":"10.1007","volume":"53","author":[{"given":"Nimra","family":"Habib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baby","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas Ali","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"11680_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105451","author":"M Motiei","year":"2024","unstructured":"Motiei M, Abu-Dawud R, Rel\u00f3gio A, Assaf C (2024) Circadian rhythms in haematological malignancies: therapeutic potential and personalised interventions. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105451","journal-title":"EBioMedicine"},{"key":"11680_CR2","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-014-1574-7","volume":"71","author":"G Sancar","year":"2014","unstructured":"Sancar G, Brunner M (2014) Circadian clocks and energy metabolism. Cell Mol Life Sci 71:2667\u20132680","journal-title":"Cell Mol Life Sci"},{"key":"11680_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/B978-0-12-396971-2.00009-9","volume":"119","author":"L Fu","year":"2013","unstructured":"Fu L, Kettner NM (2013) The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci 119:221\u2013282","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"9","key":"11680_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1289\/ehp.10200","volume":"115","author":"RG Stevens","year":"2007","unstructured":"Stevens RG, Blask DE, Brainard GC, Hansen J, Lockley SW, Provencio I, Reinlib L (2007) Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 115(9):1357\u20131362","journal-title":"Environ Health Perspect"},{"issue":"6530","key":"11680_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0951","volume":"371","author":"KB Koronowski","year":"2021","unstructured":"Koronowski KB, Sassone-Corsi P (2021) Communicating clocks shape circadian homeostasis. Science 371(6530):eabd0951","journal-title":"Science"},{"issue":"10","key":"11680_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1158\/2159-8290.CD-20-0413","volume":"10","author":"M Pariollaud","year":"2020","unstructured":"Pariollaud M, Lamia KA (2020) Cancer in the fourth dimension: what is the impact of circadian disruption? Cancer Discov 10(10):1455\u20131464","journal-title":"Cancer Discov"},{"issue":"4","key":"11680_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000228","volume":"17","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lahens NF, Zhang S, Bedont J, Field JM, Sehgal A (2019) G1\/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLoS Biol 17(4):e3000228","journal-title":"PLoS Biol"},{"issue":"2","key":"11680_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","volume":"24","author":"T Papagiannakopoulos","year":"2016","unstructured":"Papagiannakopoulos T, Bauer MR, Davidson SM, Heimann M, Subbaraj L, Bhutkar A, Jacks T (2016) Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab 24(2):324\u2013331","journal-title":"Cell Metab"},{"issue":"42","key":"11680_CR9","doi-asserted-by":"publisher","first-page":"eaaz4530","DOI":"10.1126\/sciadv.aaz4530","volume":"6","author":"I Aiello","year":"2020","unstructured":"Aiello I, Fedele MM, Rom\u00e1n F, Marpegan L, Caldart C, Chiesa JJ, Paladino N (2020) Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation. Sci Adv 6(42):eaaz4530","journal-title":"Sci Adv"},{"issue":"8","key":"11680_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli G, Lam MTY, Panda S (2019) Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends cancer 5(8):475\u2013494","journal-title":"Trends cancer"},{"issue":"2","key":"11680_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0748730410395527","volume":"26","author":"MY Yang","year":"2011","unstructured":"Yang MY, Yang WC, Lin PM, Hsu JF, Hsiao HH, Liu YC, Lin SF (2011) Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms 26(2):136\u2013148","journal-title":"J Biol Rhythms"},{"issue":"6","key":"11680_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819","volume":"10","author":"JAB Bispo","year":"2020","unstructured":"Bispo JAB, Pinheiro PS, Kobetz EK (2020) Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med 10(6):a034819","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11680_CR13","doi-asserted-by":"crossref","unstructured":"Pandey S, Singh R, Habib N, Singh V, Kushwaha R, Tripathi AK, Mahdi AA (2023) Expression of CXCL8 (IL-8) in the pathogenesis of T-cell acute lymphoblastic leukemia patients.\u00a0Cureus\u00a015(9)","DOI":"10.7759\/cureus.45929"},{"issue":"3","key":"11680_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/clockssleep7030033","volume":"7","author":"LS da Cunha","year":"2025","unstructured":"da Cunha LS, Nogueira BMD, de Pinho Pessoa FMC, Machado CB, de Sousa Oliveira D, de Moraes Filho MO, Moreira-Nunes CA (2025) Evaluation of the circadian rhythm component cipc (clock-interacting pacemaker) in leukemogenesis: A literature review and bioinformatics approach. Clocks Sleep 7(3):33","journal-title":"Clocks Sleep"},{"key":"11680_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000447076","volume":"43","author":"G Juliusson","year":"2016","unstructured":"Juliusson G, Hough R (2016) Leukemia. Prog Tumor Res 43:87\u2013100","journal-title":"Prog Tumor Res"},{"issue":"8","key":"11680_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrm3629","volume":"14","author":"C Bertoli","year":"2013","unstructured":"Bertoli C, Skotheim JM, De Bruin RA (2013) Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 14(8):518\u2013528","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"11680_CR17","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.jmb.2020.04.003","volume":"432","author":"E Farshadi","year":"2020","unstructured":"Farshadi E, van Der Horst GT, Chaves I (2020) Molecular links between the circadian clock and the cell cycle. J Mol Biol 432(12):3515\u20133524","journal-title":"J Mol Biol"},{"issue":"2","key":"11680_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cell.2016.03.015","volume":"165","author":"RV Puram","year":"2016","unstructured":"Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M, Tothova Z, Tejero H, Heckl D, J\u00e4r\u00e5s M, Chen MC, Li H, Tamayo A, Cowley GS, Rozenblatt-Rosen O, Al-Shahrour F, Regev A, Ebert BL (2016) Core circadian clock genes regulate leukemia stem cells in AML. Cell 165(2):303\u2013316","journal-title":"Cell"},{"issue":"15","key":"11680_CR19","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1158\/0008-5472.CAN-19-0566","volume":"79","author":"AA Shafi","year":"2019","unstructured":"Shafi AA, Knudsen KE (2019) Cancer and the circadian clock. Cancer Res 79(15):3806\u20133814","journal-title":"Cancer Res"},{"issue":"3","key":"11680_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/jb\/mvq069","volume":"148","author":"ZL Zeng","year":"2010","unstructured":"Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ (2010) Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem 148(3):319\u2013326","journal-title":"J Biochem"},{"key":"11680_CR21","doi-asserted-by":"publisher","DOI":"10.5334\/jcr.147","volume":"15","author":"S Rahman","year":"2017","unstructured":"Rahman S, Al-Hallaj AS, Nedhi A, Gmati G, Al Jama H, Trivilegio T, Ahmed K, Jama HA, Mashour A, Askar AA, Boudjelal M (2017) Differential expression of circadian genes in leukemia and a possible role for Sirt1 in restoring the circadian clock in chronic myeloid leukemia. J Circadian Rhythms 15:3","journal-title":"J Circadian Rhythms"},{"issue":"6","key":"11680_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030692","volume":"10","author":"CB Green","year":"2018","unstructured":"Green CB (2018) Circadian posttranscriptional regulatory mechanisms in mammals. Cold Spring Harb Perspect Biol 10(6):a030692","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"11680_CR23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/carcin\/bgi075","volume":"26","author":"ST Chen","year":"2005","unstructured":"Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26(7):1241\u20131246","journal-title":"Carcinogenesis"},{"issue":"1","key":"11680_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RA (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74\u201388","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"11680_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4161\/cc.8.6.7869","volume":"8","author":"L Borgs","year":"2009","unstructured":"Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, Malgrange B (2009) Cell \u201ccircadian\u201d cycle: new role for mammalian core clock genes. Cell Cycle 8(6):832\u2013837","journal-title":"Cell Cycle"},{"key":"11680_CR26","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.2147\/IJGM.S328184","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T, Ma L (2021) PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells. Int J Gen Med 22:7077\u20137087","journal-title":"Int J Gen Med"},{"issue":"8","key":"11680_CR27","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1182\/blood-2005-01-0358","volume":"106","author":"S Gery","year":"2005","unstructured":"Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP (2005) Transcription profiling of C\/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106(8):2827\u20132836","journal-title":"Blood"},{"issue":"6","key":"11680_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cmet.2015.09.003","volume":"22","author":"BJ Altman","year":"2015","unstructured":"Altman BJ, Hsieh AL, Sengupta A, Krishnanaiah SY, Stine ZE, Walton ZE, Dang CV (2015) MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab 22(6):1009\u20131019","journal-title":"Cell Metab"},{"issue":"1","key":"11680_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu J, Huang P, Lee CC (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111(1):41\u201350","journal-title":"Cell"},{"key":"11680_CR30","first-page":"525","volume":"17","author":"CC Lee","year":"2006","unstructured":"Lee CC (2006) Tumor suppression by the mammalian Period genes. Cancer Causes Control 17:525\u2013530","journal-title":"Cancer Causes Control"},{"issue":"12","key":"11680_CR31","first-page":"6615","volume":"35","author":"MY Yang","year":"2015","unstructured":"Yang MY, Lin PM, Hsiao HH, Hsu JF, Lin HYH, Hsu CM, Lin SF (2015) Up-regulation of PER3 expression is correlated with better clinical outcome in acute leukemia. Anticancer Res 35(12):6615\u20136622","journal-title":"Anticancer Res"},{"key":"11680_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11033-013-2841-7","volume":"41","author":"S Rana","year":"2014","unstructured":"Rana S, Munawar M, Shahid A, Malik M, Ullah H, Fatima W, Mahmood S (2014) Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep 41:95\u2013103","journal-title":"Mol Biol Rep"},{"issue":"8","key":"11680_CR33","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3748\/wjg.v20.i8.1986","volume":"20","author":"T Karantanos","year":"2014","unstructured":"Karantanos T, Theodoropoulos G, Pektasides D, Gazouli M (2014) Clock genes: their role in colorectal cancer. World J Gastroenterol 20(8):1986","journal-title":"World J Gastroenterol"},{"key":"11680_CR34","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S328184","author":"Y Liu","year":"2021","unstructured":"Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T, Ma L (2021) PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells. Int J Gen Med. https:\/\/doi.org\/10.2147\/IJGM.S328184","journal-title":"Int J Gen Med"},{"key":"11680_CR35","doi-asserted-by":"publisher","first-page":"e04883","DOI":"10.7554\/eLife.04883","volume":"4","author":"SJ Papp","year":"2015","unstructured":"Papp SJ, Huber AL, Jordan SD, Kriebs A, Nguyen M, Moresco JJ, Lamia KA (2015) DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. Elife 4:e04883","journal-title":"Elife"},{"issue":"1","key":"11680_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41467-020-20513-5","volume":"12","author":"AA Shafi","year":"2021","unstructured":"Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, Knudsen KE (2021) The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun 12(1):401","journal-title":"Nat Commun"},{"issue":"14","key":"11680_CR37","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.7150\/jca.25213","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Yu Y, Sun S, Zhang T, Wang M (2018) Cry 1 regulates the clock gene network and promotes proliferation and migration via the Akt\/P53\/P21 pathway in human osteosarcoma cells. J Cancer 9(14):2480","journal-title":"J Cancer"},{"issue":"47","key":"11680_CR38","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/sj.onc.1210758","volume":"26","author":"RA Van Etten","year":"2007","unstructured":"Van Etten RA (2007) Aberrant cytokine signaling in leukemia. Oncogene 26(47):6738\u20136749","journal-title":"Oncogene"},{"key":"11680_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exphem.2016.10.005","volume":"45","author":"X Zhou","year":"2017","unstructured":"Zhou X, Li Z, Zhou J (2017) Tumor necrosis factor \u03b1 in the onset and progression of leukemia. Exp Hematol 45:17\u201326","journal-title":"Exp Hematol"},{"key":"11680_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","volume":"43","author":"S Binder","year":"2018","unstructured":"Binder S, Luciano M, Horejs-Hoeck J (2018) The cytokine network in acute myeloid leukemia (AML): a focus on pro-and anti-inflammatory mediators. Cytokine Growth Factor Rev 43:8\u201315","journal-title":"Cytokine Growth Factor Rev"},{"issue":"15","key":"11680_CR41","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.3390\/ijms23158212","volume":"23","author":"ABA Sanford","year":"2022","unstructured":"Sanford ABA, da Cunha LS, Machado CB, de Pinho Pessoa FMC, Silva ANDS, Ribeiro RM, Moreira-Nunes CA (2022) Circadian rhythm dysregulation and leukemia development: the role of clock genes as promising biomarkers. Int J Mol Sci 23(15):8212","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11680_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034347","volume":"7","author":"M Hanoun","year":"2012","unstructured":"Hanoun M, Eisele L, Suzuki M, Greally JM, H\u00fcttmann A, Aydin S, Scholtysik R, Klein-Hitpass L, D\u00fchrsen U, D\u00fcrig J (2012) Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS ONE 7(3):e34347","journal-title":"PLoS ONE"},{"issue":"27","key":"11680_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101416118","volume":"118","author":"AB Chan","year":"2021","unstructured":"Chan AB, Parico GCG, Fribourgh JL, Ibrahim LH, Bollong MJ, Partch CL, Lamia KA (2021) CRY2 missense mutations suppress P53 and enhance cell growth. Proc Natl Acad Sci U S A 118(27):e2101416118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"11680_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2015.03.039","volume":"460","author":"P Lin","year":"2015","unstructured":"Lin P, An F, Xu X, Zhao L, Liu L, Liu N, Wang P, Liu J, Wang L, Li M (2015) Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice. Biochem Biophys Res Commun 460(2):362\u2013367","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"11680_CR45","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cub.2010.05.027","volume":"20","author":"X Zheng","year":"2010","unstructured":"Zheng X, Sehgal A (2010) AKT and TOR signaling set the pace of the circadian pacemaker. Curr Biol 20(13):1203\u20131208","journal-title":"Curr Biol"},{"issue":"29","key":"11680_CR46","doi-asserted-by":"publisher","first-page":"20794","DOI":"10.1074\/jbc.C700070200","volume":"282","author":"JH Um","year":"2007","unstructured":"Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH (2007) Activation of 5\u2032-AMP-activated kinase with diabetes drug metformin induces casein kinase I\u025b (CKI\u025b)-dependent degradation of clock protein mPer2. J Biol Chem 282(29):20794\u201320798","journal-title":"J Biol Chem"},{"issue":"10","key":"11680_CR47","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1158\/0008-5472.CAN-12-3876","volume":"73","author":"J Liang","year":"2013","unstructured":"Liang J, Mills GB (2013) AMPK: a contextual oncogene or tumor suppressor? Cancer Res 73(10):2929\u20132935","journal-title":"Cancer Res"},{"issue":"5","key":"11680_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","volume":"17","author":"Y Saito","year":"2015","unstructured":"Saito Y, Chapple RH, Lin A, Kitano A, Nakada D (2015) AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell 17(5):585\u2013596","journal-title":"Cell Stem Cell"},{"issue":"3","key":"11680_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031060","volume":"21","author":"C Tarantelli","year":"2020","unstructured":"Tarantelli C, Lupia A, Stathis A, Bertoni F (2020) Is there a role for dual PI3K\/mTOR inhibitors for patients affected with lymphoma? Int J Mol Sci 21(3):1060","journal-title":"Int J Mol Sci"},{"key":"11680_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","volume":"59","author":"AS Alzahrani","year":"2019","unstructured":"Alzahrani AS (2019) PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol 59:125\u2013132 (Academic Press.)","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"11680_CR51","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1158\/0008-5472.CAN-04-3888","volume":"65","author":"MG Kharas","year":"2005","unstructured":"Kharas MG, Fruman DA (2005) ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. Cancer Res 65(6):2047\u20132053","journal-title":"Cancer Res"},{"issue":"12","key":"11680_CR52","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"J Bertacchini","year":"2015","unstructured":"Bertacchini J, Heidari N, Mediani L, Capitani S, Shahjahani M, Ahmadzadeh A, Saki N (2015) Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci 72(12):2337\u20132347","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"11680_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"Nepstad I, Hatfield KJ, Gr\u00f8nnings\u00e6ter IS, Reikvam H (2020) The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci 21(8):2907","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11680_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113192","volume":"417","author":"H Liu","year":"2022","unstructured":"Liu H, Hussain Z, Xie Q, Yan X, Zeng C, Zhou G, Cao S (2022) Targeting PI3K\/AKT\/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax. Exp Cell Res 417(2):113192","journal-title":"Exp Cell Res"},{"issue":"6","key":"11680_CR55","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/09168451.2015.1136885","volume":"80","author":"Y Morishita","year":"2016","unstructured":"Morishita Y, Miura D, Kida S (2016) PI3K regulates BMAL1\/CLOCK-mediated circadian transcription from the Dbp promoter. Biosci Biotechnol Biochem 80(6):1131\u20131140","journal-title":"Biosci Biotechnol Biochem"},{"issue":"10-12","key":"11680_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/ars.2021.0059","volume":"37","author":"H Yoshitane","year":"2022","unstructured":"Yoshitane H, Imamura K, Okubo T, Otobe Y, Kawakami S, Ito S, Takumi T, Hattori K, Naguro I, Ichijo H, Fukada Y (2022) mTOR-AKT signaling in cellular clock resetting triggered by osmotic stress. Antioxid Redox Signal 37(10\u201312):631\u2013646","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"11680_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2007.10.027","volume":"12","author":"A Gutierrez","year":"2007","unstructured":"Gutierrez A, Look AT (2007) NOTCH and PI3K-AKT pathways intertwined. Cancer Cell 12(5):411\u2013413","journal-title":"Cancer Cell"},{"issue":"56","key":"11680_CR58","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","volume":"21","author":"T Skorski","year":"2002","unstructured":"Skorski T (2002) BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene 21(56):8591\u20138604","journal-title":"Oncogene"},{"issue":"3","key":"11680_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger JA, Wiestner A (2018) Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer 18(3):148\u2013167","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"11680_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13608","volume":"57","author":"MR Khezri","year":"2024","unstructured":"Khezri MR, Hsueh HY, Mohammadipanah S, Khalili Fard J, Ghasemnejad\u2010Berenji M (2024) The interplay between the PI3K\/AKT pathway and circadian clock in physiologic and cancer\u2010related pathologic conditions. Cell Prolif 57(7):e13608","journal-title":"Cell Prolif"},{"issue":"11","key":"11680_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4(11):a011254","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11680_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3896-y","volume":"18","author":"CS Goldsmith","year":"2018","unstructured":"Goldsmith CS, Kim SM, Karunarathna N, Neuendorff N, Toussaint LG, Earnest DJ, Bell-Pedersen D (2018) Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness. BMC Cancer 18:1\u201313","journal-title":"BMC Cancer"},{"key":"11680_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407703-4.00001-3","volume":"84","author":"CS Goldsmith","year":"2013","unstructured":"Goldsmith CS, Bell-Pedersen D (2013) Diverse roles for MAPK signaling in circadian clocks. Adv Genet 84:1\u201339","journal-title":"Adv Genet"},{"issue":"3","key":"11680_CR64","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1182\/blood.2025030558","volume":"147","author":"B Popescu","year":"2026","unstructured":"Popescu B, Jones MF, Piao M, Tran E, Koh A, Lomeli I, Smith CC (2026) Multiselective RAS (ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML. Blood 147(3):276\u2013289","journal-title":"Blood"},{"issue":"17","key":"11680_CR65","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.4161\/cc.7.17.6516","volume":"7","author":"RM de Paula","year":"2008","unstructured":"de Paula RM, Lamb TM, Bennett L, Bell-Pedersen D (2008) A connection between MAPK pathways and circadian clocks. Cell Cycle 7(17):2630\u20132634","journal-title":"Cell Cycle"},{"issue":"1","key":"11680_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"11680_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13046-023-02799-7","volume":"42","author":"E Murgo","year":"2023","unstructured":"Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, Giambra V (2023) The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia. J Exp Clin Cancer Res 42(1):218","journal-title":"J Exp Clin Cancer Res"},{"key":"11680_CR68","first-page":"1","volume":"21","author":"H Wang","year":"2021","unstructured":"Wang H, Fu Y (2021) NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK\/STAT3 signaling pathway. BMC Cancer 21:1\u201312","journal-title":"BMC Cancer"},{"issue":"4","key":"11680_CR69","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cell.2011.12.024","volume":"148","author":"W Luo","year":"2012","unstructured":"Luo W, Sehgal A (2012) Regulation of circadian behavioral output via a microrna-JAK\/STAT circuit. Cell 148(4):765\u2013779","journal-title":"Cell"},{"issue":"19","key":"11680_CR70","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.jmb.2012.10.022","volume":"425","author":"N Mehta","year":"2013","unstructured":"Mehta N, Cheng HYM (2013) Micro-managing the circadian clock: the role of micrornas in biological timekeeping. J Mol Biol 425(19):3609\u20133624","journal-title":"J Mol Biol"},{"issue":"1","key":"11680_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-023-01929-1","volume":"23","author":"D Liang","year":"2024","unstructured":"Liang D, Wang Q, Zhang W, Tang H, Song C, Yan Z, Wang H (2024) JAK\/STAT in leukemia: a clinical update. Mol cancer 23(1):25","journal-title":"Mol cancer"},{"issue":"5341","key":"11680_CR72","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","volume":"278","author":"V Lacronique","year":"1997","unstructured":"Lacronique V, Boureux A, Della Valle V, Poirel H, Quang CT, Mauchauffe M, Bernard OA (1997) A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278(5341):1309\u20131312","journal-title":"Science"},{"issue":"12","key":"11680_CR73","first-page":"3891","volume":"95","author":"C Carron","year":"2000","unstructured":"Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT, Ghysdael J (2000) TEL-JAK2 transgenic mice develop T-cell leukemia. Blood, The Journal of the American Society of Hematology 95(12):3891\u20133899","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"11680_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","volume":"12","author":"JC Aster","year":"2017","unstructured":"Aster JC, Pear WS, Blacklow SC (2017) The varied roles of notch in cancer. Annu Rev Pathol 12(1):245\u2013275","journal-title":"Annu Rev Pathol"},{"issue":"48","key":"11680_CR75","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Ferrando AA (2006) NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci 103(48):18261\u201318266","journal-title":"Proc Natl Acad Sci"},{"issue":"7346","key":"11680_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09999","volume":"473","author":"A Klinakis","year":"2011","unstructured":"Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, Aifantis I (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nat 473(7346):230\u2013233","journal-title":"Nat"},{"issue":"7","key":"11680_CR77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.tcb.2007.07.001","volume":"17","author":"RV Kondratov","year":"2007","unstructured":"Kondratov RV, Antoch MP (2007) Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 17(7):311\u2013317","journal-title":"Trends Cell Biol"},{"issue":"4","key":"11680_CR78","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/ijms18040873","volume":"18","author":"A Shostak","year":"2017","unstructured":"Shostak A (2017) Circadian clock, cell division, and cancer: from molecules to organism. Int J Mol Sci 18(4):873","journal-title":"Int J Mol Sci"},{"issue":"5694","key":"11680_CR79","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306(5694):269\u2013271","journal-title":"Science"},{"issue":"12","key":"11680_CR80","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1517\/17425247.2011.618184","volume":"8","author":"F L\u00e9vi","year":"2011","unstructured":"L\u00e9vi F, Okyar A (2011) Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics. Expert Opin Drug Deliv 8(12):1535\u20131541","journal-title":"Expert Opin Drug Deliv"},{"key":"11680_CR81","doi-asserted-by":"crossref","unstructured":"Lin A, Fang X, Zhang P, Zhang N, Liu Z, Cheng Q, Luo P (2025) Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade.\u00a0J Natl Cancer Cent","DOI":"10.1016\/j.jncc.2025.09.007"},{"key":"11680_CR82","unstructured":"Zhu Y et al (2022) Circadian rhythm disruption and cancer: mechanistic insights and clinical implications. Int J Mol Sci"},{"key":"11680_CR83","unstructured":"Arruga F et al (2020) NOTCH signaling in chronic lymphocytic leukemia: biological and clinical relevance. Leukemia"},{"issue":"17","key":"11680_CR84","doi-asserted-by":"publisher","first-page":"R713","DOI":"10.1016\/S0960-9822(01)00417-1","volume":"11","author":"TP Yamaguchi","year":"2001","unstructured":"Yamaguchi TP (2001) Heads or tails: Wnts and anterior\u2013posterior patterning. Curr Biol 11(17):R713\u2013R724","journal-title":"Curr Biol"},{"issue":"1","key":"11680_CR85","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20(1):781\u2013810","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"11680_CR86","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ni1164","volume":"6","author":"AW Duncan","year":"2005","unstructured":"Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Reya T (2005) Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6(3):314\u2013322","journal-title":"Nat Immunol"},{"issue":"3","key":"11680_CR87","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1084\/jem.20071875","volume":"205","author":"K Petropoulos","year":"2008","unstructured":"Petropoulos K, Arseni N, Schessl C, Stadler CR, Rawat VP, Deshpande AJ, Rawat VPS, Heilmeier B, Hiddemann W, Quintanilla-Martinez L, Bohlander SK, Feuring-Buske M, Buske C (2008) A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J Exp Med 205(3):515\u2013522","journal-title":"J Exp Med"},{"key":"11680_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/jbiol22","volume":"4","author":"R Habas","year":"2005","unstructured":"Habas R, Dawid IB (2005) Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 4:1\u20134","journal-title":"J Biol"},{"issue":"7035","key":"11680_CR89","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nat 434(7035):843\u2013850","journal-title":"Nat"},{"issue":"3","key":"11680_CR90","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/1078-0432.CCR-08-0124","volume":"15","author":"JY Yang","year":"2009","unstructured":"Yang JY, Hung MC (2009) A new fork for clinical application: targeting forkhead transcription factors in cancer. Clin Cancer Res 15(3):752\u2013757","journal-title":"Clin Cancer Res"},{"issue":"6","key":"11680_CR91","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","volume":"73","author":"A de Brach\u00e8neCoomans","year":"2016","unstructured":"de Brach\u00e8neCoomans A, Demoulin JB (2016) FOXO transcription factors in cancer development and therapy. Cell Mol Life Sci 73(6):1159\u20131172","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"11680_CR92","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cub.2014.04.018","volume":"24","author":"I Chaves","year":"2014","unstructured":"Chaves I, van der Horst GT, Schellevis R, Nijman RM, Koerkamp MG, Holstege FC, Smidt MP, Hoekman MF (2014) Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription. Curr Biol 24(11):1248\u20131255","journal-title":"Curr Biol"},{"issue":"46","key":"11680_CR93","doi-asserted-by":"publisher","first-page":"35386","DOI":"10.1074\/jbc.M110.129288","volume":"285","author":"C Crumbley","year":"2010","unstructured":"Crumbley C, Wang Y, Kojetin DJ, Burris TP (2010) Characterization of the core mammalian clock component, NPAS2, as a REV-ERB\u03b1\/ROR\u03b1 target gene. J Biol Chem 285(46):35386\u201335392","journal-title":"J Biol Chem"},{"issue":"5","key":"11680_CR94","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nsmb925","volume":"12","author":"M Akashi","year":"2005","unstructured":"Akashi M, Takumi T (2005) The orphan nuclear receptor ROR\u03b1 regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 12(5):441\u2013448","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"11680_CR95","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-\u03baB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369\u20132380","journal-title":"EMBO J"},{"issue":"3","key":"11680_CR96","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.yexmp.2005.11.004","volume":"80","author":"M De Martinis","year":"2006","unstructured":"De Martinis M, Franceschi C, Monti D, Ginaldi L (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80(3):219\u2013227","journal-title":"Exp Mol Pathol"},{"key":"11680_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1143001","volume":"10","author":"M Qu","year":"2023","unstructured":"Qu M (2023) Molecular crosstalk between circadian clock and cancer and therapeutic implications. Front Nutr 10:1143001","journal-title":"Front Nutr"},{"issue":"1","key":"11680_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","volume":"7","author":"F Fagiani","year":"2022","unstructured":"Fagiani F, Di Marino D, Romagnoli A, Travelli C, Voltan D, Di Cesare Mannelli L, Lanni C (2022) Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther 7(1):41","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"11680_CR99","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12672-024-01643-4","volume":"15","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Rabbani SA, Ali AA, Alfaouri IGA, Al Nsairat H, Al-Ani IH, Aljabali AA, Rizzo M, Patoulias D, Khan MA, Parvez S, El-Tanani Y (2024) Circadian rhythms and cancer: implications for timing in therapy. Discov Oncol 15(1):767","journal-title":"Discov Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11680-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:02:51Z","timestamp":1773921771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11680"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11680-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"517"}}